Concepts (235)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Arrest | 6 | 2021 | 311 | 2.240 |
Why?
|
| Dynamins | 6 | 2024 | 48 | 1.860 |
Why?
|
| Myocardial Reperfusion Injury | 6 | 2024 | 56 | 1.550 |
Why?
|
| Cardiopulmonary Resuscitation | 6 | 2024 | 247 | 1.550 |
Why?
|
| Mitochondrial Dynamics | 8 | 2024 | 59 | 1.540 |
Why?
|
| Emergency Medicine | 4 | 2024 | 136 | 1.360 |
Why?
|
| National Institutes of Health (U.S.) | 5 | 2024 | 135 | 1.190 |
Why?
|
| Myocardial Infarction | 2 | 2025 | 385 | 0.800 |
Why?
|
| Community Health Services | 1 | 2023 | 81 | 0.730 |
Why?
|
| Mitochondrial Proteins | 4 | 2017 | 128 | 0.710 |
Why?
|
| Mitochondria, Heart | 6 | 2024 | 48 | 0.680 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2021 | 149 | 0.620 |
Why?
|
| Exercise | 1 | 2023 | 353 | 0.620 |
Why?
|
| GTP Phosphohydrolases | 3 | 2015 | 80 | 0.610 |
Why?
|
| Biomedical Research | 3 | 2024 | 435 | 0.610 |
Why?
|
| Hypothermia, Induced | 2 | 2017 | 90 | 0.570 |
Why?
|
| Myocytes, Cardiac | 7 | 2024 | 313 | 0.570 |
Why?
|
| Quinazolinones | 2 | 2015 | 15 | 0.540 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2017 | 12 | 0.530 |
Why?
|
| Dichloroacetic Acid | 1 | 2017 | 12 | 0.530 |
Why?
|
| Mice, Inbred C57BL | 9 | 2025 | 3430 | 0.510 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2015 | 185 | 0.490 |
Why?
|
| Acute Generalized Exanthematous Pustulosis | 1 | 2015 | 1 | 0.460 |
Why?
|
| Financing, Organized | 1 | 2015 | 12 | 0.440 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2015 | 12 | 0.440 |
Why?
|
| Emergency Service, Hospital | 4 | 2021 | 582 | 0.440 |
Why?
|
| Drug Eruptions | 1 | 2015 | 34 | 0.440 |
Why?
|
| Mice | 13 | 2025 | 12233 | 0.440 |
Why?
|
| Staphylococcal Skin Infections | 1 | 2015 | 25 | 0.440 |
Why?
|
| Exanthema | 1 | 2015 | 39 | 0.430 |
Why?
|
| Animals | 27 | 2025 | 28041 | 0.430 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2015 | 91 | 0.420 |
Why?
|
| Cardiotonic Agents | 1 | 2015 | 88 | 0.420 |
Why?
|
| Pyloric Stenosis, Hypertrophic | 1 | 2014 | 3 | 0.420 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 85 | 0.410 |
Why?
|
| Mentors | 1 | 2015 | 95 | 0.410 |
Why?
|
| Vomiting | 1 | 2014 | 108 | 0.400 |
Why?
|
| Myocardium | 7 | 2025 | 570 | 0.390 |
Why?
|
| Reactive Oxygen Species | 7 | 2024 | 502 | 0.370 |
Why?
|
| Cardiomyopathies | 3 | 2023 | 299 | 0.350 |
Why?
|
| Doxorubicin | 3 | 2017 | 284 | 0.310 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 836 | 0.300 |
Why?
|
| Ductus Arteriosus | 2 | 2023 | 28 | 0.290 |
Why?
|
| Hypertension, Pulmonary | 3 | 2020 | 369 | 0.290 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 755 | 0.270 |
Why?
|
| Humans | 23 | 2025 | 93615 | 0.270 |
Why?
|
| Disease Models, Animal | 6 | 2021 | 2491 | 0.230 |
Why?
|
| Myofibrils | 6 | 1998 | 20 | 0.230 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 2 | 2019 | 103 | 0.220 |
Why?
|
| Heart | 5 | 2023 | 522 | 0.220 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2025 | 14 | 0.220 |
Why?
|
| Fentanyl | 1 | 2025 | 86 | 0.210 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2015 | 137 | 0.210 |
Why?
|
| Cells, Cultured | 11 | 2017 | 2828 | 0.210 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2024 | 24 | 0.200 |
Why?
|
| Calcium | 4 | 2024 | 1175 | 0.200 |
Why?
|
| Immunoblotting | 2 | 2015 | 273 | 0.200 |
Why?
|
| Respiration | 1 | 2025 | 269 | 0.200 |
Why?
|
| Fellowships and Scholarships | 1 | 2024 | 146 | 0.190 |
Why?
|
| Respiratory Insufficiency | 1 | 2025 | 202 | 0.190 |
Why?
|
| Crime Victims | 1 | 2023 | 55 | 0.190 |
Why?
|
| Emergency Medical Services | 1 | 2025 | 269 | 0.180 |
Why?
|
| Acute Lung Injury | 1 | 2022 | 68 | 0.170 |
Why?
|
| Violence | 1 | 2023 | 152 | 0.170 |
Why?
|
| Faculty | 1 | 2021 | 36 | 0.170 |
Why?
|
| Hydrogen Peroxide | 2 | 2020 | 164 | 0.170 |
Why?
|
| Homeostasis | 1 | 2024 | 460 | 0.170 |
Why?
|
| Heart Rate | 1 | 2024 | 508 | 0.170 |
Why?
|
| Oxygen Consumption | 3 | 2025 | 238 | 0.170 |
Why?
|
| Female | 12 | 2023 | 48779 | 0.170 |
Why?
|
| Tissue Distribution | 1 | 2021 | 290 | 0.160 |
Why?
|
| Microglia | 1 | 2021 | 123 | 0.160 |
Why?
|
| Analgesics, Opioid | 1 | 2025 | 513 | 0.160 |
Why?
|
| Mitochondria | 3 | 2020 | 612 | 0.160 |
Why?
|
| Altitude Sickness | 1 | 2020 | 12 | 0.160 |
Why?
|
| Myocardial Stunning | 1 | 2020 | 10 | 0.160 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2021 | 104 | 0.160 |
Why?
|
| Electron Transport Complex I | 1 | 2020 | 34 | 0.150 |
Why?
|
| Superoxides | 1 | 2020 | 75 | 0.150 |
Why?
|
| Radiopharmaceuticals | 1 | 2021 | 203 | 0.150 |
Why?
|
| Sirtuin 3 | 2 | 2017 | 36 | 0.150 |
Why?
|
| Myocardial Contraction | 5 | 1998 | 188 | 0.150 |
Why?
|
| Sepsis | 1 | 2023 | 388 | 0.140 |
Why?
|
| Random Allocation | 2 | 2020 | 307 | 0.140 |
Why?
|
| Positron-Emission Tomography | 1 | 2021 | 350 | 0.140 |
Why?
|
| Signal Transduction | 2 | 2025 | 3498 | 0.140 |
Why?
|
| Hospital Costs | 1 | 2019 | 116 | 0.140 |
Why?
|
| Male | 10 | 2025 | 44578 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2010 | 364 | 0.140 |
Why?
|
| Oxygen | 3 | 2023 | 769 | 0.130 |
Why?
|
| Glucose | 1 | 2021 | 692 | 0.130 |
Why?
|
| Hemodynamics | 2 | 2020 | 714 | 0.130 |
Why?
|
| Vasoconstriction | 2 | 2020 | 88 | 0.130 |
Why?
|
| United States | 4 | 2024 | 7645 | 0.130 |
Why?
|
| Lignans | 1 | 2017 | 6 | 0.130 |
Why?
|
| Biphenyl Compounds | 1 | 2017 | 60 | 0.130 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2019 | 217 | 0.110 |
Why?
|
| Aconitate Hydratase | 1 | 2015 | 11 | 0.110 |
Why?
|
| DNA, Mitochondrial | 1 | 2016 | 200 | 0.110 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2017 | 151 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 338 | 0.110 |
Why?
|
| Mass Media | 1 | 2015 | 26 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 333 | 0.110 |
Why?
|
| Peristalsis | 1 | 2014 | 10 | 0.100 |
Why?
|
| Hyperthermia, Induced | 1 | 2014 | 75 | 0.100 |
Why?
|
| DNA Damage | 1 | 2016 | 389 | 0.100 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 1723 | 0.100 |
Why?
|
| Abdomen | 1 | 2014 | 120 | 0.100 |
Why?
|
| Stomach | 1 | 2014 | 113 | 0.100 |
Why?
|
| Survival Rate | 1 | 2017 | 1950 | 0.100 |
Why?
|
| Calcineurin Inhibitors | 1 | 2013 | 53 | 0.100 |
Why?
|
| Rats | 8 | 2017 | 4042 | 0.090 |
Why?
|
| Tacrolimus | 1 | 2013 | 372 | 0.090 |
Why?
|
| Heat-Shock Proteins | 1 | 2013 | 177 | 0.090 |
Why?
|
| Patient Care Team | 1 | 2014 | 298 | 0.090 |
Why?
|
| Infant, Newborn | 2 | 2015 | 2482 | 0.090 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2013 | 232 | 0.090 |
Why?
|
| Skin | 1 | 2015 | 576 | 0.090 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 555 | 0.090 |
Why?
|
| Nitric Oxide | 2 | 2010 | 281 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 885 | 0.090 |
Why?
|
| Flavanones | 1 | 2011 | 35 | 0.090 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2011 | 98 | 0.090 |
Why?
|
| Ultrasonography | 1 | 2014 | 702 | 0.090 |
Why?
|
| Adult | 3 | 2021 | 27955 | 0.080 |
Why?
|
| Brain | 1 | 2021 | 2375 | 0.080 |
Why?
|
| Actins | 1 | 1993 | 467 | 0.080 |
Why?
|
| Child | 1 | 2021 | 7359 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2017 | 1243 | 0.080 |
Why?
|
| Proanthocyanidins | 1 | 2009 | 12 | 0.080 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2009 | 83 | 0.070 |
Why?
|
| Immunosuppressive Agents | 1 | 2013 | 990 | 0.070 |
Why?
|
| Rabbits | 2 | 2023 | 613 | 0.070 |
Why?
|
| Myosin Heavy Chains | 2 | 1998 | 86 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 1056 | 0.070 |
Why?
|
| Plant Extracts | 1 | 2009 | 247 | 0.060 |
Why?
|
| Infant | 1 | 2014 | 3222 | 0.060 |
Why?
|
| Mice, Knockout | 2 | 2025 | 2121 | 0.060 |
Why?
|
| Hypoxia | 2 | 2022 | 675 | 0.060 |
Why?
|
| Middle Aged | 4 | 2025 | 27621 | 0.060 |
Why?
|
| Animals, Newborn | 4 | 2013 | 519 | 0.060 |
Why?
|
| Receptors, Opioid, mu | 1 | 2025 | 49 | 0.060 |
Why?
|
| Cell Survival | 2 | 2022 | 1003 | 0.060 |
Why?
|
| Transcription Factors | 1 | 2013 | 1690 | 0.060 |
Why?
|
| Pandemics | 2 | 2021 | 875 | 0.050 |
Why?
|
| Brain Stem | 1 | 2025 | 163 | 0.050 |
Why?
|
| Research Support as Topic | 1 | 2024 | 89 | 0.050 |
Why?
|
| Rotenone | 1 | 2023 | 17 | 0.050 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2025 | 180 | 0.050 |
Why?
|
| Electron Transport | 1 | 2023 | 72 | 0.050 |
Why?
|
| Electrons | 1 | 2023 | 51 | 0.050 |
Why?
|
| X-Ray Microtomography | 1 | 2023 | 101 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 1998 | 2020 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2025 | 477 | 0.040 |
Why?
|
| Macrophages, Alveolar | 1 | 2022 | 66 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2023 | 300 | 0.040 |
Why?
|
| Glycolysis | 1 | 2022 | 187 | 0.040 |
Why?
|
| Cannula | 1 | 2021 | 54 | 0.040 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2022 | 170 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2024 | 623 | 0.040 |
Why?
|
| Lung | 2 | 2020 | 1365 | 0.040 |
Why?
|
| Time Factors | 3 | 2016 | 5406 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2021 | 10186 | 0.040 |
Why?
|
| Dyspnea | 1 | 2020 | 86 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2011 | 1130 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2019 | 157 | 0.030 |
Why?
|
| Microtubules | 1 | 1998 | 134 | 0.030 |
Why?
|
| Vinculin | 1 | 1997 | 9 | 0.030 |
Why?
|
| Verapamil | 2 | 1997 | 32 | 0.030 |
Why?
|
| Transcriptome | 1 | 2023 | 760 | 0.030 |
Why?
|
| Integrin beta1 | 1 | 1997 | 34 | 0.030 |
Why?
|
| Osmolar Concentration | 1 | 1997 | 168 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 283 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2013 | 1735 | 0.030 |
Why?
|
| DNA Adducts | 1 | 2016 | 22 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 494 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 1997 | 416 | 0.030 |
Why?
|
| DNA Glycosylases | 1 | 2016 | 21 | 0.030 |
Why?
|
| Deoxyguanosine | 1 | 2016 | 28 | 0.030 |
Why?
|
| Contractile Proteins | 1 | 1996 | 52 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2016 | 140 | 0.030 |
Why?
|
| Cardiomegaly | 1 | 2016 | 111 | 0.030 |
Why?
|
| Length of Stay | 1 | 2019 | 828 | 0.030 |
Why?
|
| Cell Death | 1 | 2016 | 253 | 0.030 |
Why?
|
| Sirtuins | 1 | 2016 | 79 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2017 | 729 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2021 | 3061 | 0.030 |
Why?
|
| Chloroquine | 1 | 1993 | 13 | 0.020 |
Why?
|
| Registries | 1 | 2019 | 996 | 0.020 |
Why?
|
| Optic Atrophy, Autosomal Dominant | 1 | 2013 | 4 | 0.020 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2013 | 17 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1993 | 121 | 0.020 |
Why?
|
| Sarcomeres | 1 | 1993 | 26 | 0.020 |
Why?
|
| Familial Primary Pulmonary Hypertension | 1 | 2013 | 64 | 0.020 |
Why?
|
| Exercise Tolerance | 1 | 2013 | 63 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2016 | 467 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2016 | 752 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2013 | 81 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2013 | 133 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 1993 | 405 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2011 | 32 | 0.020 |
Why?
|
| DNA Fragmentation | 1 | 2011 | 65 | 0.020 |
Why?
|
| Models, Animal | 1 | 2013 | 281 | 0.020 |
Why?
|
| Microscopy, Confocal | 3 | 1998 | 282 | 0.020 |
Why?
|
| Scutellaria baicalensis | 1 | 2011 | 26 | 0.020 |
Why?
|
| rho-Associated Kinases | 1 | 2013 | 161 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 2756 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 672 | 0.020 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2010 | 32 | 0.020 |
Why?
|
| Oxidants | 1 | 2010 | 86 | 0.020 |
Why?
|
| Grape Seed Extract | 1 | 2009 | 4 | 0.020 |
Why?
|
| Vitis | 1 | 2009 | 19 | 0.020 |
Why?
|
| Protective Agents | 1 | 2009 | 34 | 0.020 |
Why?
|
| Chick Embryo | 1 | 2009 | 176 | 0.020 |
Why?
|
| Seeds | 1 | 2009 | 62 | 0.020 |
Why?
|
| Nitric Oxide Synthase | 1 | 2009 | 123 | 0.020 |
Why?
|
| Apoptosis | 1 | 2013 | 1719 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2013 | 1260 | 0.020 |
Why?
|
| Cell Nucleus | 2 | 1998 | 602 | 0.010 |
Why?
|
| Microscopy, Electron | 2 | 1996 | 433 | 0.010 |
Why?
|
| Aged | 1 | 2019 | 20469 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1998 | 303 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1997 | 54 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1997 | 65 | 0.010 |
Why?
|
| Cytoplasm | 1 | 1998 | 277 | 0.010 |
Why?
|
| Biological Transport | 1 | 1998 | 399 | 0.010 |
Why?
|
| Physical Stimulation | 1 | 1996 | 54 | 0.010 |
Why?
|
| Transfection | 1 | 1997 | 878 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1997 | 554 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1997 | 373 | 0.010 |
Why?
|
| Nifedipine | 1 | 1995 | 24 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1995 | 81 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1997 | 661 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 1998 | 1790 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 1995 | 248 | 0.010 |
Why?
|